16-81924693-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002661.5(PLCG2):​c.2417+1099C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.243 in 152,174 control chromosomes in the GnomAD database, including 4,522 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 4522 hom., cov: 33)

Consequence

PLCG2
NM_002661.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.262

Publications

6 publications found
Variant links:
Genes affected
PLCG2 (HGNC:9066): (phospholipase C gamma 2) The protein encoded by this gene is a transmembrane signaling enzyme that catalyzes the conversion of 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate to 1D-myo-inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) using calcium as a cofactor. IP3 and DAG are second messenger molecules important for transmitting signals from growth factor receptors and immune system receptors across the cell membrane. Mutations in this gene have been found in autoinflammation, antibody deficiency, and immune dysregulation syndrome and familial cold autoinflammatory syndrome 3. [provided by RefSeq, Mar 2014]
PLCG2 Gene-Disease associations (from GenCC):
  • autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • familial cold autoinflammatory syndrome 3
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002661.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002661.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLCG2
NM_002661.5
MANE Select
c.2417+1099C>G
intron
N/ANP_002652.2P16885
PLCG2
NM_001425749.1
c.2417+1099C>G
intron
N/ANP_001412678.1P16885
PLCG2
NM_001425750.1
c.2417+1099C>G
intron
N/ANP_001412679.1P16885

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PLCG2
ENST00000564138.6
TSL:1 MANE Select
c.2417+1099C>G
intron
N/AENSP00000482457.1P16885
PLCG2
ENST00000902427.1
c.2570+1099C>G
intron
N/AENSP00000572486.1
PLCG2
ENST00000565054.7
TSL:5
c.2417+1099C>G
intron
N/AENSP00000520638.1P16885

Frequencies

GnomAD3 genomes
AF:
0.243
AC:
36962
AN:
152056
Hom.:
4514
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.270
Gnomad AMI
AF:
0.134
Gnomad AMR
AF:
0.189
Gnomad ASJ
AF:
0.226
Gnomad EAS
AF:
0.185
Gnomad SAS
AF:
0.306
Gnomad FIN
AF:
0.249
Gnomad MID
AF:
0.301
Gnomad NFE
AF:
0.240
Gnomad OTH
AF:
0.234
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.243
AC:
37009
AN:
152174
Hom.:
4522
Cov.:
33
AF XY:
0.241
AC XY:
17965
AN XY:
74402
show subpopulations
African (AFR)
AF:
0.270
AC:
11218
AN:
41522
American (AMR)
AF:
0.190
AC:
2904
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
783
AN:
3466
East Asian (EAS)
AF:
0.185
AC:
961
AN:
5184
South Asian (SAS)
AF:
0.307
AC:
1480
AN:
4826
European-Finnish (FIN)
AF:
0.249
AC:
2632
AN:
10588
Middle Eastern (MID)
AF:
0.296
AC:
87
AN:
294
European-Non Finnish (NFE)
AF:
0.240
AC:
16324
AN:
67982
Other (OTH)
AF:
0.236
AC:
498
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1468
2937
4405
5874
7342
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.144
Hom.:
257
Bravo
AF:
0.235
Asia WGS
AF:
0.239
AC:
831
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
2.3
DANN
Benign
0.67
PhyloP100
-0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7192724;
hg19: chr16-81958298;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.